Rapid Multiplex POC Tests for detection of COVID-19

用于检测 COVID-19 的快速多重 POC 测试

• 批准号: 551387-2020
• 负责人: Akbari, Mohsen
• 金额: $ 3.64万
• 依托单位: University of Victoria
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=702926
• 关键词: Rapid; Multiplex; POC; Tests; detection

The current coronavirus outbreak highlights the importance of point-of-care (POC) rapid screening tools to identify and understand COVID-19 spread within the population. As countries work on flattening the disease curve, it is anticipated that billions of COVID-19 tests will be required for the next 12-24 months. Also, it is widely understood that the next pandemic will not be a matter of "if" but rather a matter of "when". To address this urgent need, we have partnered with Sensoreal Inc., a Montreal-based biotech company, to develop a rapid multiplex test based on their proprietary microfluidic liquid-handling technology. The envisioned product consists of a customizable, analyzer, and disposable microfluidic cartridge. Such a highly flexible liquid handling platform miniaturizes and automates existing laboratory procedures suitable for the broad range of rapid testing kit applications. This innovation will allow fast responses to future epidemics using similar technology to enable a global strategy that prevents an out of control pandemic.

目前的冠状病毒暴发突显了护理点(POC)快速筛查工具的重要性，以识别和了解新冠肺炎在人群中的传播。随着各国努力平坦疾病曲线，预计在未来12-24个月内将需要数十亿次新冠肺炎测试。此外，人们普遍认为，下一次大流行将不是“如果”的问题，而是“何时”的问题。为了满足这一迫切需求，我们与总部位于蒙特利尔的生物技术公司SensorealInc.合作，开发了一种基于他们专有的微流控液体处理技术的快速多重测试。设想的产品由可定制的、分析器和一次性微流体盒组成。这种高度灵活的液体处理平台使现有的实验室程序小型化和自动化，适用于广泛的快速检测试剂盒应用。这项创新将允许使用类似的技术对未来的流行病做出快速反应，从而能够制定一项全球战略，防止大流行失控。